Daewoong Co., Ltd. (KRX:003090)
22,800
-150 (-0.65%)
Last updated: Apr 29, 2026, 1:40 PM KST
Daewoong Revenue
In the year 2025, Daewoong had annual revenue of 2.07T KRW with 6.79% growth. Daewoong had revenue of 516.33B in the quarter ending December 31, 2025, with 2.47% growth.
Revenue
2,068.37B
Revenue Growth
+6.79%
P/S Ratio
0.45
Revenue / Employee
5.46B
Employees
379
Market Cap
938.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,068.37B | 131.45B | 6.79% |
| Dec 31, 2024 | 1,936.92B | 123.08B | 6.79% |
| Dec 31, 2023 | 1,813.84B | 116.50B | 6.86% |
| Dec 31, 2022 | 1,697.34B | 185.96B | 12.30% |
| Dec 31, 2021 | 1,511.37B | 156.04B | 11.51% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ildong Pharmaceutical | 566.93B |
| Boryung | 1,017.43B |
| DongKook Pharmaceutical | 926.88B |
| Huons Global | 847.45B |
| Chong Kun Dang Pharmaceutical | 1,692.40B |
| JW Pharmaceutical | 775.30B |
| Bukwang Pharmaceutical | 200.71B |
| Dong-A Socio Holdings | 1,429.77B |
Daewoong News
- 3 months ago - AEON Biopharma Completes BPD Type 2a Meeting With FDA - Nasdaq